World's Best Scientists 2026 revealed!
Magdalena Plebanski

Magdalena Plebanski

D-Index & Metrics

Immunology

D-Index
70
Citations
18809
World Ranking
2402
National Ranking
96

Magdalena Plebanski publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Magdalena Plebanski sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 289 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Magdalena Plebanski D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Magdalena Plebanski sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 70 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Magdalena Plebanski is a researcher affiliated with RMIT University in Australia. Their work is primarily situated within the fields of Medicine and Immunology and Microbiology, with 130 and 60 publications respectively. The subfields that characterize their research include Immunology, Oncology, Infectious Diseases, Molecular Biology, and Public Health, Environmental and Occupational Health.

The research topics frequently addressed by Magdalena Plebanski cover a variety of areas, including:

  • SARS-CoV-2 and COVID-19 Research
  • Immunotherapy and Immune Responses
  • Immune Cell Function and Interaction
  • Ovarian cancer diagnosis and treatment
  • Immune cells in cancer
  • Immune Response and Inflammation
  • Cancer Immunotherapy and Biomarkers

Magdalena Plebanski's recent publications illustrate their engagement with contemporary challenges in immunology, oncology, and infectious diseases. Notable papers include:

  • "Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis," 2021, published in Frontiers in Oncology
  • "Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine," 2022, published in ACS Nano
  • "Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2," 2020, published in Cells
  • "Antioxidant-Based Medicinal Properties of Stingless Bee Products: Recent Progress and Future Directions," 2020, published in Biomolecules
  • "Poly(amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccines," 2020, published in Science Advances

Their collaborative work often involves frequent partnerships with co-authors such as Katie L. Flanagan, Jennifer C. Boer, Kirsty Wilson, Apriliana E. R. Kartikasari, and Kanta Subbarao.

Magdalena Plebanski has contributed extensively to journals that frequently publish their work. These publication venues include:

  • Cancers (10 publications)
  • Frontiers in Immunology (7 publications)
  • Vaccines (6 publications)
  • International Journal of Molecular Sciences (4 publications)
  • Advanced Healthcare Materials (3 publications)

Best Publications

  • Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

    Romain Daillère;Romain Daillère;Romain Daillère;Marie Vétizou;Marie Vétizou;Marie Vétizou;Nadine Waldschmitt;Takahiro Yamazaki;Takahiro Yamazaki

  • Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors

    Theodora Fifis;Anita Gamvrellis;Blessing Crimeen-Irwin;Geoffrey A Pietersz

  • Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells.

    Britta C. Urban;David J. P. Ferguson;Arnab Pain;Nick Willcox

  • Pathogen recognition and development of particulate vaccines: does size matter?

    Sue Dong Xiang;Anja Scholzen;Gabriela Minigo;Cassandra David

  • Two-dimensional single-cell patterning with one cell per well driven by surface acoustic waves

    David John Collins;Belinda Joan Morahan;Jose Garcia-Bustos;Christian Daniel Doerig

  • Sex and Gender Differences in the Outcomes of Vaccination over the Life Course.

    Katie L. Flanagan;Ashley L. Fink;Magdalena Plebanski;Sabra L. Klein

  • Induction of peptide-specific primary cytotoxic T lymphocyte responses from human peripheral blood

    Magdalena Plebanski;Catherine E. M. Allsopp;Michael Aidoo;Hugh Reyburn

  • Plasmodium falciparum induces Foxp3hi CD4 T cells independent of surface PfEMP1 expression via small soluble parasite components

    Anja Scholzen;Anja Scholzen;Brian Mark Cooke;Magdalena Plebanski

  • Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer

    Nirmala Chandralega Kampan;Mutsa Tatenda Madondo;Orla M McNally;Michael Quinn

  • Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus

    Patricia L Mottram;David Leong;Blessing Crimeen-Irwin;Simone Gloster

  • A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease.

    William H H Reece;Margaret Pinder;Philip K Gothard;Paul Milligan

  • Association of Malaria Parasite Population Structure, HLA, and Immunological Antagonism

    Sarah C. Gilbert;Magdalena Plebanski;Sunetra Gupta;Joanne Morris

  • Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis.

    Apriliana E. R. Kartikasari;Cesar S. Huertas;Arnan Mitchell;Magdalena Plebanski

  • IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling

    Shuo Li;Marie-Paule Lefranc;John J. Miles;John J. Miles;John J. Miles;Eltaf Alamyar

  • Induction of CD8+ T cells using heterologous prime-boost immunisation strategies

    Jorg Schneider;Sarah C. Gilbert;Carolyn M. Hannan;Pilar Degano

  • Vaccines that facilitate antigen entry into dendritic cells.

    Anita Gamvrellis;David Leong;Jennifer C Hanley;Sue Dong Xiang

  • Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes.

    Sarah C Gilbert;Jörg Schneider;Carolyn M Hannan;Jiang Ting Hu

  • A protein particle vaccine containing multiple malaria epitopes.

    Sarah C. Gilbert;Magdalena Plebanski;Stephen J. Harris;Catherine E.M. Allsopp

  • The microgenderome revealed: sex differences in bidirectional interactions between the microbiota, hormones, immunity and disease susceptibility

    Ravichandra Vemuri;Kristyn E. Sylvia;Sabra L. Klein;Samuel C. Forster

  • Potent Induction of Focused Th1-Type Cellular and Humoral Immune Responses by RTS,S/SBAS2, a Recombinant Plasmodium falciparum Malaria Vaccine

    A. Lalvani;P. Moris;G. Voss;A. A. Pathan

  • Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835].

    Vasso Apostolopoulos;Geoffrey A Pietersz;Anastasios Tsibanis;Annivas Tsikkinis

Frequent Co-Authors

Katie L. Flanagan
Katie L. Flanagan RMIT University
Adrian V. S. Hill
Adrian V. S. Hill University of Oxford
Sarah C. Gilbert
Sarah C. Gilbert University of Oxford
Vasso Apostolopoulos
Vasso Apostolopoulos RMIT University
Geoffrey L. Smith
Geoffrey L. Smith University of Oxford
Cordelia Selomulya
Cordelia Selomulya University of New South Wales
Ross L. Coppel
Ross L. Coppel Monash University
Eric J. Gowans
Eric J. Gowans University of Adelaide
Andrew J. McMichael
Andrew J. McMichael University of Oxford
Hilton Whittle
Hilton Whittle London School of Hygiene & Tropical Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology in the USA, exploring related healthcare degrees can expand career opportunities. Nursing, for instance, offers numerous pathways closely linked to immunological research and patient care. Understanding dnp salary transparency can help prospective students evaluate the financial benefits of pursuing a Doctor of Nursing Practice degree, which integrates advanced clinical skills with immunological knowledge.

Nurses looking to specialize can benefit from programs like the fnp to acnp bridge program online, enabling a smooth transition from Family Nurse Practitioner to Acute Care Nurse Practitioner, roles that demand strong immunology backgrounds to manage complex patient cases.

Those seeking a faster route to specialize in family healthcare might consider the accelerated fnp programs. These provide a streamlined approach, allowing students to quickly integrate advanced nursing practices that often intersect with immunological concerns.

Lastly, for individuals without a prior nursing background, exploring online nursing programs for non nurses opens doors to foundational healthcare education, creating a strong base to advance into specialized fields like immunology and nurse practitioner roles.

Best Scientists Citing Magdalena Plebanski

Trending Scientists